Complete financial analysis of Tobii Dynavox AB (publ) (TDVOX.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tobii Dynavox AB (publ), a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Gold79 Mines Ltd. (AUU.V) Income Statement Analysis – Financial Results
- Nobilis Health Corp. (NRTSF) Income Statement Analysis – Financial Results
- Bright Minds Biosciences Inc. (DRUG.CN) Income Statement Analysis – Financial Results
- Onion Global Limited (OG) Income Statement Analysis – Financial Results
- Equity Metals Corporation (EQTY.V) Income Statement Analysis – Financial Results
Tobii Dynavox AB (publ) (TDVOX.ST)
About Tobii Dynavox AB (publ)
Tobii Dynavox AB (Publ) develops and sells assistive technology products for communication in Sweden and internationally. The company provides technology and solutions for augmentative and alternative communication for people with disabilities. It also offers speech generating devices and eye trackers; software and apps for communication, computer access, special education, and analysis; accessories, including keyguards, chargers, mounts, and cases; games; and books. The company was founded in 1983 and is headquartered in Danderyd, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.61B | 1.22B | 871.20M | 895.20M | 908.80M |
| Cost of Revenue | 518.90M | 428.50M | 301.00M | 303.50M | 315.20M |
| Gross Profit | 1.09B | 787.80M | 570.20M | 591.70M | 593.60M |
| Gross Profit Ratio | 67.84% | 64.77% | 65.45% | 66.10% | 65.32% |
| Research & Development | 163.50M | 138.40M | 117.30M | 108.60M | 121.30M |
| General & Administrative | 196.40M | 129.90M | 83.60M | 67.90M | 66.70M |
| Selling & Marketing | 584.80M | 450.80M | 312.70M | 288.10M | 308.90M |
| SG&A | 781.20M | 580.70M | 396.30M | 356.00M | 375.60M |
| Other Expenses | 0.00 | -7.60M | -900.00K | -10.20M | -700.00K |
| Operating Expenses | 944.70M | 711.50M | 512.70M | 454.40M | 496.20M |
| Cost & Expenses | 1.46B | 1.14B | 813.70M | 757.90M | 811.40M |
| Interest Income | 1.80M | 1.00M | 300.00K | 300.00K | 23.40M |
| Interest Expense | 39.90M | 21.70M | 19.40M | 22.40M | 23.40M |
| Depreciation & Amortization | 65.20M | 117.10M | 94.80M | 86.30M | 83.20M |
| EBITDA | 214.90M | 199.40M | 154.80M | 213.50M | 184.20M |
| EBITDA Ratio | 13.32% | 16.39% | 17.77% | 23.85% | 20.27% |
| Operating Income | 149.70M | 82.30M | 60.00M | 127.20M | 101.00M |
| Operating Income Ratio | 9.28% | 6.77% | 6.89% | 14.21% | 11.11% |
| Total Other Income/Expenses | -30.70M | -22.60M | -17.40M | -33.90M | -16.40M |
| Income Before Tax | 119.00M | 53.70M | 40.50M | 103.40M | 81.00M |
| Income Before Tax Ratio | 7.38% | 4.42% | 4.65% | 11.55% | 8.91% |
| Income Tax Expense | 14.90M | 5.10M | 10.70M | -26.50M | 13.30M |
| Net Income | 104.10M | 48.60M | 29.80M | 129.80M | 67.70M |
| Net Income Ratio | 6.45% | 4.00% | 3.42% | 14.50% | 7.45% |
| EPS | 0.99 | 0.46 | 0.30 | 1.30 | 0.68 |
| EPS Diluted | 0.98 | 0.46 | 0.30 | 1.30 | 0.68 |
| Weighted Avg Shares Out | 104.85M | 104.85M | 100.49M | 99.80M | 99.80M |
| Weighted Avg Shares Out (Dil) | 106.55M | 105.39M | 100.49M | 99.80M | 99.80M |
Source: https://incomestatements.info
Category: Stock Reports